Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | RAB9A | P51151 | 3/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | PHGDH | O43175 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | CASP7 | P55210 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.56 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL175272 | 1.00 | MEN1 (0.71) | MEN1KMT2ARAB9AGAACYP3A4 | |
| SCHEMBL11332310 | 0.86 | KMT2A (0.73) | MEN1KMT2ARAB9AGAACYP3A4 | |
| SCHEMBL6857920 | 0.86 | KMT2A (0.73) | MEN1KMT2ARAB9AGAACYP3A4 | |
| SCHEMBL8925968 | 0.85 | KMT2A (0.67) | MEN1KMT2ARAB9AGAACYP3A4 | |
| SCHEMBL6377318 | 0.85 | KMT2A (0.71) | MEN1KMT2ARAB9AGAACYP3A4 | |
| SCHEMBL30388225 | 0.85 | KMT2A (0.71) | MEN1KMT2ARAB9AGAACYP3A4 | |
| SCHEMBL1745798 | 0.85 | KMT2A (0.71) | MEN1KMT2ARAB9AGAACYP3A4 | |
| SCHEMBL11551428 | 0.84 | POLB (0.75) | MEN1KMT2ARAB9AGAACYP3A4 | |
| SCHEMBL169338 | 0.84 | POLB (0.54) | MEN1KMT2ARAB9AGAACYP3A4 | |
| SCHEMBL169339 | 0.84 | POLB (0.54) | MEN1KMT2ARAB9AGAACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190043731-A1 | TWO-STAGE BAKE PHOTORESIST WITH RELEASABLE QUENCHER | INTEL CORPORATION | 2019-02-07 | — | — | US | claimed |
| WO-2017176282-A1 | TWO-STAGE BAKE PHOTORESIST WITH RELEASABLE QUENCHER | INTEL CORPORATION (US) | 2017-10-12 | — | — | WO | claimed |
| EP-1317430-B1 | (2-AZABICYCLO [2.2.1]HEPT-7-YL)METHANOL DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS | MERCK PATENT GMBH (DE) | 2005-05-18 | — | — | EP | claimed |
| US-20040039045-A1 | (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists | MERCK PATENT GMBH (DE) | 2004-02-26 | — | — | US | claimed |
| EP-1007530-A1 | 6-O-SUBSTITUTED ERYTHROMYCIN COMPOUNDS AND METHOD FOR MAKING SAME | ABBOTT LABORATORIES (US) | 2000-06-14 | — | — | EP | claimed |
| US-6075011-A | 6-O-substituted erythromycin compounds and method for making same | ABBOTT LABORATORIES (US) | 2000-06-13 | — | — | US | claimed |
| WO-1997042206-A1 | 6-O-SUBSTITUTED ERYTHROMYCIN COMPOUNDS AND METHOD FOR MAKING SAME | ABBOTT LABORATORIES (US) | 1997-11-13 | — | — | WO | claimed |
| US-20240208898-A1 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2024-06-27 | — | — | US | disclosed |
| US-11955343-B2 | Two-stage bake photoresist with releasable quencher | INTEL CORPORATION (US) | 2024-04-09 | — | — | US | disclosed |
| US-20240071917-A1 | ADVANCED LITHOGRAPHY AND SELF-ASSEMBLED DEVICES | INTEL CORP (US) | 2024-02-29 | — | — | US | disclosed |
| EP-4313013-A2 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | Dana-Farber Cancer Institute, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| US-11854787-B2 | Advanced lithography and self-assembled devices | INTEL CORPORATION (US) | 2023-12-26 | — | — | US | disclosed |
| CN-117279629-A | Enamine N-oxide: synthesis and use in hypoxia responsive prodrugs and imaging agents | 达纳－法伯癌症研究所公司 | 2023-12-22 | — | — | CN | disclosed |
| US-6075011-A | 6-O-substituted erythromycin compounds and method for making same | ABBOTT LABORATORIES (US) | 2000-06-13 | — | — | US | disclosed |
| US-6017682-A | Solid state extension method | INTERNATONAL BUSINESS MACHINES CORPORATION (US) | 2000-01-25 | — | — | US | disclosed |
| CN-1223648-A | Novel thiophene derivatives and drug compositions containing the same | YAMANOUCHI PHARMA CO LTD (JP) | 1999-07-21 | — | — | CN | disclosed |
| WO-1997042206-A1 | 6-O-SUBSTITUTED ERYTHROMYCIN COMPOUNDS AND METHOD FOR MAKING SAME | ABBOTT LABORATORIES (US) | 1997-11-13 | — | — | WO | disclosed |
| CN-1148813-A | Contrast medium | NYCOMED SERUTA CO (US) | 1997-04-30 | — | — | CN | disclosed |
| US-5382637-A | Solid state chain extension polymerization between Lewis acid oligomers and deblocked Lewis bases | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1995-01-17 | — | — | US | disclosed |
| EP-0216273-B1 | METHOD OF MANUFACTURING DIPHENYLMETHANE DICARBAMIC ACID ESTERS | NIPPON KOKAN KABUSHIKI KAISHA (JP) | 1990-11-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040039045-A1 | (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists | CHRNA1, CHRNA10, CHRNB1 | MEN1 2964/4885KMT2A 1979/4885RAB9A 1504/4885 |
| US-20240208898-A1 | ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS | ENO1, HIF1A, HIF1AN | MEN1 535/4885KMT2A 1870/4885RAB9A 3234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.